Olav Haraldseth

Profilbilde
Epostolav.haraldseth@ntnu.no
Fasttelefon 72828040
Mobiltelefon 98468940
KontoradresseAHL*342.03.015, Prinsesse Kristinas gate 3
StillingProfessor
EnhetInstitutt for sirkulasjon og bildediagnostikk


Legg til i min adressebok


 

Born:                           1956

Present position:           Professor, MI Lab director

Degrees:                      MD, PhD [dr. med.]

 

Education

1992                PhD in Medicine [dr. med.], NTNU, Trondheim, Norway.

                        Thesis: “NMR spectroscopy of cerebral ischemia and reperfusion in rat”

1984                Medical Doctor, University of Bergen.

 

Work experience

2007 -             Director of medical imaging centre (SFI) “MI Lab” (www.ntnu.no/milab)

2006 - 07        Dean for research, Faculty of Medicine, NTNU

2005                Head of Department of Circulation and Medical Imaging, NTNU

2002 - 05        Vice-head of Department of Circulation and Medical Imaging, NTNU

1998 - present Professor in MR, NTNU, Trondheim, Norway

1991 - 97        Research scientist, Sintef, Trondheim, Norway

1988 - 91        Research fellowship, the Research Council of Norway

1985 - 87        Hospital physician, Harstad and Trondheim, Norway

Special assignments active in 2008

·      Appointed by European Science Foundation to be main author of a Science Policy Briefing on “Medical Imaging for Improved Patient Care”

·      Leader of “Whole animal imaging network” in the national FUGE technology platform in Molecular Imaging (NorMIC)

·      Leader of “The Norwegian Interdisciplinary Research Training Programme in Medical Imaging”.

·      Research leader, Department of Medical Imaging, St. Olavs Hospital

·      NTNU contact person for European Technology Platform in Nanomedicine.

·      Member of National User Committee for the PET Centre in Oslo

 

 Main Research Interest

Clinical and preclinical application of new functional and molecular MR methods for information about tissue physiology and organ function in brain, heart and cancer research.